0001493152-21-008025.txt : 20210405
0001493152-21-008025.hdr.sgml : 20210405
20210405183130
ACCESSION NUMBER: 0001493152-21-008025
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210331
FILED AS OF DATE: 20210405
DATE AS OF CHANGE: 20210405
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: CARR EDWARD
CENTRAL INDEX KEY: 0001273351
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-15771
FILM NUMBER: 21807238
MAIL ADDRESS:
STREET 1: 1330 AVENUE OF THE AMERICAS, 33RD FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10019
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ABEONA THERAPEUTICS INC.
CENTRAL INDEX KEY: 0000318306
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 830221517
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1330 AVENUE OF THE AMERICAS, 33RD FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10019
BUSINESS PHONE: 646-813-4701
MAIL ADDRESS:
STREET 1: 1330 AVENUE OF THE AMERICAS, 33RD FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10019
FORMER COMPANY:
FORMER CONFORMED NAME: PLASMATECH BIOPHARMACEUTICALS INC
DATE OF NAME CHANGE: 20140922
FORMER COMPANY:
FORMER CONFORMED NAME: ACCESS PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19960209
FORMER COMPANY:
FORMER CONFORMED NAME: CHEMEX PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19920703
4
1
ownership.xml
X0306
4
2021-03-31
0
0000318306
ABEONA THERAPEUTICS INC.
ABEO
0001273351
CARR EDWARD
1330 AVENUE OF THE AMERICAS, 33RD FLOOR
NEW YORK
NY
10019
0
1
0
0
Chief Accounting Officer
Common stock
2021-04-01
4
S
0
20445
1.8521
D
226291
D
Common stock
2021-04-05
4
S
0
35000
1.7956
D
191291
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Edward Carr on February 23, 2021.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $1.7893 to $1.97, inclusive. The reporting person undertakes to provide to the Issuer, any security holder, or the Staff of the SEC, upon request, full information regarding the number of shares disposed at each separate price within the ranges set forth in this footnote.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $1.76 to $1.85, inclusive. The reporting person undertakes to provide to the Issuer, any security holder, or the Staff of the SEC, upon request, full information regarding the number of shares disposed at each separate price within the ranges set forth in this footnote.
/s/ Edward Carr
2021-04-05